Initiating Coverage:Indegene - 24th September, 2026
We initiate coverage on Indegene with a BUY recommendation and a DCF-based target price of Rs 705/share, implying an upside of 18% from the CMP.
98 Views
𝛼SK or SearchENTITY
Indegene (INDGN IN)
Indegene (INDGN IN)
42
Analysis
Health Care • India
Indegene is an Indian company that offers digitally-led commercialization services to biopharmaceutical and healthcare enterprises globally. It provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. The company is headquartered in Bangalore, India, and was founded in 1998.
morex